CGI Life Sciences expert Balaji Kuppuswamy explores the questions of whether it is the role of the pharmaceutical industry to engage with patients, and how that relationship is and should be managed.
As the COVID-19 pandemic rapidly spread across the globe in the early months of 2020, the Montreal Heart Institute (MHI) responded by launching a major clinical study to test a potential treatment for the illness. Funded by the Government of ...

 

500+ biotech/pharmaceutical  projects completed for 50 clients

 

Millions of Danes benefit from a  CGI-developed system for pathology

 

7 of the top 10 global pharmaceutical  companies are clients

 

CGI expertise and services help life sciences organisations increase speed, efficiency and innovation, while keeping pace with compliance demands. Key capabilities include:

  • Commercial launch and operations to simplify planning and execution and improve launch efficiency
  • Clinical services to reduce the duration of drug development timelines
  • Regulatory compliance to help clients continuously monitor clinical drug safety data across the entire product life cycle
  • Manufacturing innovation to achieve end-to-end supply chain optimisation, manufacturing execution excellence, transport management and ERP, including Industry 4.0
  • Outsourcing to improve the management and operation of company-wide infrastructures, application suites and business processes
  • Intelligent automation to increase efficiency of operations by combining advanced analytics with IoT and AI for predictive maintenance.

Industrie pharmaceutique